1592 (abacavir, or new name Ziagen) more widely available March 23.
D019380:Anti-HIV Agents / Q000600:supply & distribution / Q000627:therapeutic use*; D015224:Dideoxynucleosides / Q000009:adverse effects / Q000600:supply & distribution / Q000627:therapeutic use*; D004342:Drug Hypersensitivity; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D000099227:Abacavir
D019380:Anti-HIV Agents; D015224:Dideoxynucleosides; D000099227:Abacavir